Yi-Hsing Chen

GenMont Biotech (Taiwan)

Research Areas

• Ocular Diseases and Behçet’s Syndrome
• Systemic Lupus Erythematosus Research
• Retinal and Optic Conditions
• Retinopathy of Prematurity Studies
• Retinal Diseases and Treatments

Health Outcomes Studied

• Improved Gut Microbiota
• Improved Insulin Levels
• Improved Insulin Sensitivity
• Increased Fecal Lactobacillus reuteri Levels
• Increased Lactobacillus Levels
• Increased Probiotic B. lactis Levels
• Increased Probiotic Bacterial Count
• Reduced Obesity

Papers (4)

• 2021
  Enterococcus faecalis Endophthalmitis: Clinical Settings, Antibiotic Susceptibility, and Management Outcomes10.3390/microorganisms9050918
• 2018
  Antiobesity effect of Lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in high-energy-diet-fed rats.10.1016/j.jnutbio.2017.11.004
• 2018
  Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats.10.1039/c5fo01396h
• 2018
  The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial10.1038/s41598-018-35014-1